By apyxmedical In 2018 Shareholder News, J-PlasmaPosted December 21, 2018BOVIE MEDICAL CORPORATION FILES 510(K) SUBMISSION WITH THE FDA FOR A NEW INDICATION TO MARKET AND SELL J-PLASMA/RENUVION FOR USE IN DERMAL RESURFACING PROCEDURES READ MORE
By apyxmedical In 2018 Shareholder News, J-PlasmaPosted December 17, 2018BOVIE MEDICAL CORPORATION ANNOUNCES APPOINTMENT OF TARA H. SEMB AS CHIEF FINANCIAL OFFICER READ MORE
By apyxmedical In 2018 Shareholder News, J-PlasmaPosted December 12, 2018BOVIE MEDICAL CORPORATION ANNOUNCES CORPORATE NAME CHANGE TO APYX MEDICAL CORPORATION AND PLANS TO TRANSITION COMMON STOCK LISTING TO NASDAQ GLOBAL SELECT MARKET READ MORE
